3-Year Real-World Study on Bispecific Antibodies This observational study explores the real-world experiences of patients using bispecific antibodies for multiple myeloma treatment. We’re gathering insights on every stage—from initial awareness to quality of life after four months of treatment. Learn more here: https://healthtree.org/myeloma/curehub/private/research/EuXByoiOsjjWtVmLuu4M?utm_source=social+media&utm_medium=meta&utm_campaign=3yearbispecifics&utm_content=general